Brandywine Managers’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Hold |
18,938
| – | – | 0.22% | 32 |
|
|
2025
Q1 | $165K | Buy |
18,938
+8,865
| +88% | +$77.4K | 0.2% | 33 |
|
|
2024
Q4 | $145K | Hold |
10,073
| – | – | 0.15% | 36 |
|
|
2024
Q3 | $227K | Hold |
10,073
| – | – | 0.24% | 33 |
|
|
2024
Q2 | $196K | Hold |
10,073
| – | – | 0.21% | 34 |
|
|
2024
Q1 | $378K | Hold |
10,073
| – | – | 0.37% | 29 |
|
|
2023
Q4 | $564K | Sell |
10,073
-1,135
| -10% | -$63.5K | 0.62% | 27 |
|
|
2023
Q3 | $462K | Hold |
11,208
| – | – | 0.78% | 27 |
|
|
2023
Q2 | $626K | Hold |
11,208
| – | – | 0.41% | 30 |
|
|
2023
Q1 | $625K | Hold |
11,208
| – | – | 0.44% | 27 |
|
|
2022
Q4 | $408K | Hold |
11,208
| – | – | 1.43% | 25 |
|
|
2022
Q3 | $319K | Buy |
11,208
+2,967
| +36% | +$84.4K | 1.05% | 29 |
|
|
2022
Q2 | $373K | Hold |
8,241
| – | – | 0.91% | 28 |
|
|
2022
Q1 | $627K | Buy |
8,241
+1,024
| +14% | +$77.9K | 1.08% | 25 |
|
|
2021
Q4 | $1.08M | Hold |
7,217
| – | – | 1.22% | 14 |
|
|
2021
Q3 | $1.05M | Hold |
7,217
| – | – | 1.1% | 18 |
|
|
2021
Q2 | $1.41M | Hold |
7,217
| – | – | 1.61% | 13 |
|
|
2021
Q1 | $1.31M | Buy |
7,217
+2,917
| +68% | +$528K | 1.74% | 11 |
|
|
2020
Q4 | $609K | Hold |
4,300
| – | – | 0.84% | 25 |
|
|
2020
Q3 | $536K | Hold |
4,300
| – | – | 1.02% | 18 |
|
|
2020
Q2 | $384K | Hold |
4,300
| – | – | 1.58% | 24 |
|
|
2020
Q1 | $268K | Hold |
4,300
| – | – | 0.09% | 24 |
|
|
2019
Q4 | $328K | Hold |
4,300
| – | – | 0.1% | 36 |
|
|
2019
Q3 | $217K | Buy |
+4,300
| New | +$217K | 0.07% | 44 |
|